Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoinositide-3-kinase, catalytic, alpha polypeptide pseudogene
- Molecular classification
- Other, Pseudogene
01
Overview
The ENSG00000233995 locus corresponds to a pseudogene related to the phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA), a key enzyme in the PI3K pathway regulating cell proliferation, growth, and survival. Pseudogenes like ENSG00000233995 are non-functional genomic sequences that typically arise from duplication or retrotransposition events and do not encode functional proteins. The canonical drug target in oncology is the PIK3CA gene/protein, not its pseudogene.
- Other names
- AP000547.1PIK3CA pseudogene
Beyond the preview
Go deeper on Phosphoinositide-3-kinase, catalytic, alpha polypeptide pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phosphoinositide-3-kinase, catalytic, alpha polypeptide pseudogene.